Fractional Exhaled Nitric Oxide (FeNO) Result Prediction Factors in Children With Allergic Diseases

In about 800 children with allergic diseases (asthma, allergic rhinitis, atopic dermatitis) the investigators will retrospectively and cross-sectionally analyze the influence/correlation of diagnosis, treatment methods, allergy status (skin prick test results), lung function tests results on/with the concentration of nitric oxide in exhaled breath.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Asthma Allergic Rhinitis Atopic Dermatitis Bronchial Diseases Congenital, Hereditary, and Neonatal Diseases and Abnormalities Dermatitis Dermatitis, Atopic Genetic Diseases, Inborn Hypersensitivity Hypersensitivity, Immediate Immune System Diseases Lung Diseases Lung Diseases, Obstructive Nose Diseases Otorhinolaryngologic Diseases Respiratory Hypersensitivity Respiratory Tract Diseases Rhinitis Rhinitis, Allergic Skin Diseases Skin Diseases, Eczematous Skin Diseases, Genetic Skin and Connective Tissue Diseases

Age range

5 year–18 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Department of Pediatrics and Allergy, N. Copernicus Hospital

Lodz, 93-513, Poland

About this study

In about 800 children with allergic diseases from our Outpatient Clinic (asthma, allergic rhinitis, atopic dermatitis) we will retrospectively and cross-sectionally analyse the influence/correlation of diagnosis, treatment methods, allergy status (skin prick test results), lung function tests results on/with the concentration of nitric oxide in exhaled breath.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Children with asthma (allergic), and/or allergic rhinitis and/or atopic dermatitis

Exclusion criteria

Other chronic diseases
Asthma exacerbation
Pregnancy

Treatment and study plan

measurements of lung function tests

Procedure

Measurement of the concentration of FeNO , measurement of spirometry, plethysmography, exercise challenge test (ECT -spirometric), bronchial obstruction reversibility pharmacological test

Other names: NO analyzer- Sievers 280i analyzer, Spirometry and Plethysmography - Jaeger, Exercise provocation test treadmill- Kettler

Primary outcomes

Concentration of nitric oxide in exhaled breath.

Time frame: 1-4 months

Sponsors and collaborators

Lead sponsor

Medical University of Lodz

Other

Registry information

Official study title

FeNO Result Prediction Factors in Children With Allergic Diseases

Important dates

Study start: 2009
Primary completion: 2010
Study completion: 2010
First posted: Dec 31, 2008
Registry last updated: Feb 10, 2010

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed